|
rs1555738475
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
|
rs1568523935
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
|
rs1799971
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The authors also examined the association between the OPRM1 118A>G genetic variation and adverse effects such as nausea and vomiting.
|
31337162 |
2019 |
|
rs1799971
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The aim of this meta-analysis is to identify the predictive strength in the current literature of OPRM1-A118G polymorphism to postoperative anesthetic reactions, including nausea, vomiting, pruritus and dizziness.
|
30323865 |
2018 |
|
rs1799971
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The association of the OPRM1 A118G genetic polymorphism with side effects, such as nausea and vomiting, caused by opioids during analgesia has not been well-represented by the literature .
|
21150856 |
2011 |
|
rs1143623
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Other associations observed were only nominally significant after adjustments: NOS1 rs2682826 A allele and excessive daytime sleepiness and sleep attacks (OR = 1.75; 95%CI = 1.00-3.06, p = 0.048), SOD2 rs4880 T allele and nausea/vomiting (OR = 0.49, 95%CI = 0.25-0.94; p = 0.031), IL1β rs1143623 C allele and orthostatic hypotension (OR = 0.57, 95%CI = 0.32-1.00, p = 0.050), and NOS1 rs2682826 A allele and impulse control disorders (OR = 2.59; 95%CI = 1.09-6.19; p = 0.032).
|
30813952 |
2019 |
|
rs1695
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach.
|
30870506 |
2019 |
|
rs2682826
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Other associations observed were only nominally significant after adjustments: NOS1 rs2682826 A allele and excessive daytime sleepiness and sleep attacks (OR = 1.75; 95%CI = 1.00-3.06, p = 0.048), SOD2 rs4880 T allele and nausea/vomiting (OR = 0.49, 95%CI = 0.25-0.94; p = 0.031), IL1β rs1143623 C allele and orthostatic hypotension (OR = 0.57, 95%CI = 0.32-1.00, p = 0.050), and NOS1 rs2682826 A allele and impulse control disorders (OR = 2.59; 95%CI = 1.09-6.19; p = 0.032).
|
30813952 |
2019 |
|
rs4880
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Other associations observed were only nominally significant after adjustments: NOS1 rs2682826 A allele and excessive daytime sleepiness and sleep attacks (OR = 1.75; 95%CI = 1.00-3.06, p = 0.048), SOD2 rs4880 T allele and nausea/vomiting (OR = 0.49, 95%CI = 0.25-0.94; p = 0.031), IL1β rs1143623 C allele and orthostatic hypotension (OR = 0.57, 95%CI = 0.32-1.00, p = 0.050), and NOS1 rs2682826 A allele and impulse control disorders (OR = 2.59; 95%CI = 1.09-6.19; p = 0.032).
|
30813952 |
2019 |
|
rs6313
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The 102T/C polymorphism in the HTR2A gene had no significant effect on the nausea/vomiting as a side effect among participants treated with either CIT or SERT.
|
30221791 |
2018 |
|
rs2737703
|
|
|
0.010 |
GeneticVariation |
BEFREE |
No significant association with severity of phenotype versus genotype of the 11 SNPs was observed except for unadjusted data for rs2737703.There was no significant difference between severity or incidence of IVPCA morphine-induced nausea and vomiting and genotype (11 SNPs).
|
28640078 |
2017 |
|
rs1045642
|
|
|
0.010 |
GeneticVariation |
BEFREE |
During the acute phase, patients with the CG haplotype (C3435T and G2677T) were associated with a high risk of grade 3/4 nausea and vomiting (P = 0.003 and P = 0.026, respectively).
|
25012726 |
2014 |
|
rs2032582
|
|
|
0.010 |
GeneticVariation |
BEFREE |
During the acute phase, patients with the CG haplotype (C3435T and G2677T) were associated with a high risk of grade 3/4 nausea and vomiting (P = 0.003 and P = 0.026, respectively).
|
25012726 |
2014 |